SIIFIC Wellness Fund

What SIIFIC Wellness Fund does

SIIFIC Wellness Fund is the flagship impact investment vehicle of SIIF Impact Capital, Inc. (SIIFIC), a privately held Japanese venture capital firm founded in September 2022 by Kazu Umeda and Reiri Miura in partnership with the Japan Social Innovation and Investment Foundation (SIIF). The firm operates from a small senior team based in Shibuya, Tokyo, and invests in early- to growth-stage Japanese startups across drug development, medical devices, functional foods, and health technology platforms under four investment themes: Revolutionizing Healthcare, Empowering Holistic Well-Being, Connecting Lives, and Cultivating Local Prosperity.

The fund's core intellectual property is its impact measurement and management stack. The proprietary Seeds Framework integrates systems thinking, systems mapping, Theory of Change, and a 5 Dimensions of Impact assessment to evaluate and monitor the social and environmental outcomes of portfolio companies. SIIFIC publishes an annual Impact Performance Report aligned with Impact Frontiers norms, conducts post-investment impact KPI monitoring, and has been adopted as a case study at Oxford University Saïd Business School. Operational certifications include B Corp status, OPIM signatory, and Impact-Driven Finance Initiative signatory.

Revenue is generated through standard VC fund economics: annual management fees on committed capital plus carried interest on profitable exits. The fund completed first close in June 2023 (¥1.5 billion) and has grown through multiple closings to ¥3.66 billion AUM as of 2025, with a stated target of ¥5–6 billion. Limited partners include government-backed entities (SME Support Japan / 中小機構), major Japanese insurers (Japan Post Insurance, Tokio Marine & Nichido), pharmaceutical companies (Teikoku Seiyaku), universities (Keio), regional banks (Higo Bank), and international capital (KANETO CAPITAL MANAGEMENT, Singapore). Portfolio companies to date include J-Pharma (oncology drug development), ORTHOREBIRTH (orthopedic regenerative medicine), Proximar (land-based salmon aquaculture), Personal Health Tech (workplace health data), and C-HAS+ (C. elegans-based health-span science).

Name

SIIFIC Wellness Fund

Legal name

SIIF Impact Capital, Inc.

Website

https://siific.co.jp

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Impact Venture Capital

NAICS

Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare Access & Life Sciences Impact Funds (FSANAJAI)

akta.pro secondary industries

ESG Integration / Responsible Investment Funds (Broad ESG) (FSANAJAL), Impact / ESG Venture Capital (FSANAAAG)

Keywords

• Venture capital investing
• Impact investing
• Healthcare venture capital
• Wellness sector investments
• Fund management services

Headquarters

HQ city

Shibuya, Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Management Fees: The fund generates revenue through annual management fees charged on committed capital under management. This is a standard VC fund revenue stream providing steady recurring income based on AUM.
2. Carried Interest (Performance Fees): The fund earns carried interest on profits generated from successful portfolio company exits. This aligns fund manager incentives with investor returns and represents the primary upside in VC fund economics.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

SIIF Impact Capital, Inc. (SIIFIC) operates the SIIFIC Wellness Fund, a Japan-focused venture capital fund providing risk capital to early- to growth-stage startups in drug development, medical devices, functional foods, and health technology. The fund combines capital deployment with proprietary post-investment Impact Measurement & Management (IMM) services, using systems-thinking frameworks to track and report on social and environmental outcomes alongside financial returns.

Product overview

SIIFIC is a venture capital firm specializing in impact investing, offering a single unified fund product—the SIIFIC Wellness Fund—alongside proprietary impact measurement and management services. The fund targets innovative wellness and healthcare startups from seed to later stages, while the IMM services provide structured post-investment support using systems thinking methodologies. The four investment themes (Revolutionizing Healthcare, Empowering Holistic Well-Being, Connecting Lives, Cultivating Local Prosperity) guide portfolio selection toward achieving Wellness Equity.

Differentiator

Problem solved

Functional benefit

Brands

• SIIFIC Wellness Fund: The venture capital fund operated by SIIFIC, focused on impact investing in wellness and healthcare startups in Japan with the goal of achieving wellness equity.

Products and services

• SIIFIC Wellness Fund Venture capital fund that invests in innovative startups in the wellness and healthcare sectors with the goal of achieving both financial returns and measurable social impact (Wellness Equity). Targets startups from seed to early/later stages in drug development, medical devices, food, and services.
• Impact Measurement & Management (IMM) A post-investment impact measurement and management service that monitors impact KPIs defined during due diligence, provides hands-on support to portfolio companies, and prepares impact reports as blueprints for collective learning using systems thinking and systems map methodologies.

Quantifiable outcome

• Wellness Equity & Literacy improvement across portfolio companies
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Real Tech Fund: Japanese impact VC fund backed by several of the same institutional investors as SIIFIC, targeting deep tech and sustainability. Comparable in size, structure, and impact-first mandate, with overlapping LP ecosystem.
• MPower Partners: Japan-based venture capital firm focused on impact investing across climate, health, and equity themes. Most direct peer to SIIFIC given shared boutique impact-VC model, Japanese domicile, and explicit impact measurement focus.
• Asahi Impact Ventures (A-Fund): Japan-based impact VC backed by Asahi Group, deploying corporate capital into startups addressing health and sustainability themes. Comparable to SIIFIC in being a corporate-anchored impact fund targeting Japanese wellness and social outcomes.

Regional players

• World Innovation Lab (WiL): Japan- and US-based VC firm investing in enterprise, health, and sustainability themes with corporate LPs. Comparable as a Japanese VC with corporate-anchored LP base and cross-border ambition, though operating at larger AUM.
• ANRI: Tokyo-based early-stage VC backing Japanese startups at seed/Series A. Comparable as a boutique Japan-focused VC firm, though without the explicit impact mandate that defines SIIFIC.
• Coral Capital: Tokyo-based early-stage VC focused on Japanese and US-Japan cross-border startups. Comparable as a small, senior-focused Japanese VC firm, though not specifically impact-mandated.
• Beyond Next Ventures: Japanese VC firm specializing in deep tech and life sciences startups from universities and research institutions. Comparable in being a Japan-focused VC with healthcare/biotech exposure and a structured post-investment support model.

Broad incumbents

• Nissay Capital: Japanese VC arm of Nippon Life Insurance, investing across healthcare, environment, and technology. Comparable as a Japanese institutional VC with insurance-company LP backing and significant healthcare exposure, though broader than SIIFIC's wellness focus.
• JAFCO Group: Largest publicly listed venture capital firm in Japan with broad sector exposure including healthcare and life sciences. Comparable as a Japan VC investor in healthcare, but operates at vastly greater scale and without a pure impact mandate.
• Daiwa Corporate Investment: Japanese VC arm of Daiwa Securities Group investing in growth-stage companies including healthcare and biotech. Comparable as an established Japanese institutional VC investor in healthcare, but lacks an explicit impact-first mandate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/siific
• LinkedInlinkedin.com/company/siific

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SIIFIC Wellness Fund